Shalvata Mental Health Center, Israel
11 March 2012
The purpose of this study is to evaluate the safety and anti-depressive response of the H1 Coil TMS Device in elderly patients suffering from major depressive episode.
A randomized, sham-controlled trial is now conducted at Shalvata Mental-Health Center. Its aim is to evaluate the efficacy and safety of H1-coil Deep TMS in subjects with Major Depression, currently treated by mood stabilizers.
Contact:
Yaara Krueger
yaarakr@post.tau.ac.il
Daphna Fenchel
fenchel@post.tau.ac.il
Noah Aaron
noahaa@post.tau.ac.il
Tel: 972-9-7478644
Principal Investigator: Prof. Hilik Levkovitz
